Nitrosamines, including N-nitroso diethylamine (NDEA) have emerged as pharmaceutical impurities and carcinogenic environmental contaminants of grave public health safety concerns. This study reports on the preparation and first use of cysteine–gold nanoparticles (CysAuNPs) for colorimetric detection of NDEA in human serum albumin (HSA) under physiological conditions. Molecular docking (MD) and molecular dynamic simulation (MDS) were performed to probe the interaction between NDEA and serum albumin. UV–visible absorption and fluorescence spectroscopy, dynamic light scattering (DLS), and transmission electron microscopy (TEM) imaging were used to characterize the synthesized CysAuNPs. These CysAuNPs show a UV–visible absorbance wavelength maxima (λmax) at 377 nm and emission λmax at 623 nm. Results from DLS measurement revealed the CysAuNPs’ uniform size distribution and high polydispersity index of 0.8. Microscopic imaging using TEM showed that CysAuNPs have spherical to nanoplate-like morphology. The addition of NDEA to HSA in the presence of CysAuNPs resulted in a remarkable increase in the absorbance of human serum albumin. The interaction of NDEA–CysAuNPs–HSA is plausibly facilitated by hydrogen bonding, sulfur linkages, or by Cys–NDEA-induced electrostatic and van der Waal interactions. These are due to the disruption of the disulfide bond linkage in Cys–Cys upon the addition of NDEA, causing the unfolding of the serum albumin and the dispersion of CysAuNPs. The combined use of molecular dynamic simulation and colorimetric experiment provided complementary data that allows robust analysis of NDEA in serum samples. In addition, the low cost of the UV–visible spectrophotometer and the easy preparation and optical sensitivity of CysAuNPs sensors are desirable, allowing the low detection limit of the CysAuNPs sensors, which are capable of detecting as little as 0.35 µM NDEA in serum albumin samples, making the protocol an attractive sensor for rapid detection of nitrosamines in biological samples.
A continued interest in developing a low-cost, rapid screening method for quantifying Hg (II) and As (III) in biological samples stems from the toxic effects of human exposure to these heavy metal ions. This study reports the use of cysteine-capped gold nanoparticles (CysAuNPs) for chemical sensing, colorimetric detection, and quantification of As (III) and Hg (II) ions in human serum albumin (HSA) under physiological conditions. Zeta potential measurements indicated that the CysAuNPs have a negative surface charge, which was decreased in the presence of HSA and reversed to a positive value upon binding of As (III) and Hg (II) metal ions. Circular dichroism (CD) spectroscopy revealed changes in HSA conformation upon binding to As (III) and Hg (II) ions. X-ray fluorescence enables rapid qualitative screening for As (III) and Hg (II) ions before colorimetric quantification. The figures of merit (R2 ≥ 0.940) and the low detection limits (0.05 ppm for As (III) ions and 0.02 ppm for Hg (II)) in serum albumin demonstrate the high sensitivity of the method. The developed calibration curves correctly quantified the concentration of As (III) and Hg (II) ions of independently prepared test validation samples in HSA with an accuracy of ≥95% over a period of seven months without recalibrations, demonstrating the stability of CysAuNPs in solution and the robustness of the method for analysis of As (III) and Hg (II) ions in serum albumin.